Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane

For more information on Radiation Therapy Systems, see the Comparison Chart.

According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray


According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030. This is a compound annual growth rate (CAGR) of 8.4 percent. Leading to this growth is the increasing number of cancer cases being seen around the globe. According to the Centers for Disease Control (CDC), cancer is the second leading cause of death, following heart disease. The American Institute of Cancer Research (AICR) states that by 2030, around 25 million cases of cancer will be diagnosed every year.

CDC mortality statisticians noted in a statement to CNN that COVID-19 will end up being a leading cause of death in 2020 — in fact making it into the Top 10. The pandemic is also spiking radiotherapy market growth, and healthcare imaging has had to shift its focus to stay on top of the pandemic. “This is why several cancer specialty hospitals are either shut or have converted to COVID care centers,” according to an excerpt from the Radiotherapy Market Research Report from P&S Intelligence. “Moreover, with the uncertain supply chain, the import and export of radiotherapy systems have been hit hard. However, several hospitals are reopening their cancer wards in the present scenario, which is pushing up the number of radiotherapy treatments.”

COVID’s Effect on Cancer Treatment

In a newly released study, researchers at the University of Sydney School of Social and Political Science, alongside colleagues from Duke University, are examining how the pandemic is altering cancer treatment in both Australia and the United States. One side effect noted in Victoria is the 30 percent decrease in melanoma checks.

In addition to doctors considering the risks of administering standard treatments, the researchers have identified the suspension of clinical trial activities as a key issue as well. An analysis published in the journal Clinical Cancer Research, from the American Association for Cancer Research, outlines the benefits and drawbacks of virtual consultations, as well as the economic implications of a changed cancer treatment landscape, for both the patients and clinicians.

“In light of physical distancing restrictions due to COVID-19, standard cancer procedures are being altered or delayed, including surveillance imaging; non-emergency surgical procedures; and clinical trials,” Sydney lead and health sociologist, Professor Alex Broom, said in a statement regarding the study. “The suspension of clinical trials is especially detrimental for patients with rare cancers. For them, enrolling in a clinical trial for a promising new therapy may be the best option.”

Creative Solutions to Maximize Opportunities

The Radiotherapy Market Research Report states that in order to make the most of the increasing radiotherapy market opportunities, companies providing such solutions are engaging in collaborations, partnerships and other such co-working agreements, and lists these examples:

• Gaining distribution partners for their equipment;

• Offering clinicians a combined solution of image-guided radiotherapy systems and electronic medical record (EMR) platform; • Developing novel tracers for pre-clinical and clinical neurological and oncologic applications;

• Providing hospitals with advanced proton therapy capabilities; and

• Upgrading the motion tracking and correction technologies of their radiotherapy systems.

An example that helps illustrate this is Siemens Healthineers’ recent acquisition of a 100 percent stake in Varian Medical Systems Inc., a company active in the area of cancer research and therapy. According to a press statement, this transaction will enable Siemens to strengthen the competitiveness and independence of Siemens Healthineers. 

“As the first of the three companies in our new Siemens Ecosystem, we gave Siemens Healthineers an independent, focused setup. This approach is the core of our Vision 2020+ strategy, which we’re rigorously executing — even in the time of COVID-19. Therefore, we expressly welcome and support this acquisition since it will be a powerful driver for Siemens Healthineers. A transformational step of this kind wouldn’t have been possible in the conglomerate structure of the old Siemens AG,” said Joe Kaeser, president and CEO of Siemens AG.

“The acquisition of Varian will create a world-leading company in the area of cancer therapy — a company in which Siemens AG will participate as a strong and long-term majority shareholder,” explained Roland Busch, deputy CEO of Siemens AG. “Siemens Healthineers is excellently positioned in an attractive growth market in the global battle against cancer. The acquisition will benefit everyone — above all patients, but also the shareholders of both companies.” 


Related Content

News | Computed Tomography (CT)

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | Radiation Therapy

June 12, 2025 — According to a new report published in the American Society of Radiation Oncology journal, Practical ...

Time June 12, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Radiation Therapy

May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and ...

Time May 15, 2025
arrow
News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
Subscribe Now